Nirupama Putcha, MD
Enriched profileAssociate Professor of Medicine, Division of Pulmonary and Critical Care Medicine · Johns Hopkins University School of Medicine
Nirupama Putcha is Associate Professor of Medicine, Division of Pulmonary and Critical Care Medicine at Johns Hopkins University School of Medicine. OpenAlex indexes 260 publications with 7,567 citations (h-index 42); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 12 Oct 2026
Overview
Updated 16 Oct 2026
Nirupama Putcha, MD, is Associate Professor of Medicine, Division of Pulmonary and Critical Care Medicine at Johns Hopkins University School of Medicine. The public record shows 260 publications with 7,567 citations (h-index 42), centered on Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Smoking Behavior and Cessation. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 7 companies, 4 NIH-funded awards (2015–2026).
- Most recent indexed publication: 2026 · Annals of the American Thoracic Society
- Top research focus: Chronic Obstructive Pulmonary Disease (COPD) Research
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 102.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Sponsor: Johns Hopkins University
Industry payments
Updated 16 Oct 2026
7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20254 payments$11,671openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
- Regeneron Pharmaceuticals, Inc.Program year20221 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
69.5%beta2-Adrenergic Agonist43.2%Albuterol Sulfate Hfa100%Part D≥24 patientsCorticosteroid21.4%Trelegy Ellipta67%Breo Ellipta33%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
22.2%Corticosteroid22.2%Prednisone100%Part D≥21 patientsAnti-infectives
8.3%Macrolide Antimicrobial8.3%Azithromycin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
4 NIH research awards on record, funded 2015–2026 per NIH RePORTER. The latest:
- Clinical trial of omalizumab for allergen sensitized and exposed individuals with COPD
Johns Hopkins University
FY2026$2,669,183U01AI177195 - Clinical trial of omalizumab for allergen sensitized and exposed individuals with COPD
Johns Hopkins University
FY2026$333,467U01AI177195
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Disease modification and progression in pre-chronic obstructive pulmonary disease: an official American Thoracic Society workshop report.
Annals of the American Thoracic Society
Article2026 - Serum Immunoglobulin G Levels Are Associated with Risk for Exacerbations: An Analysis of SPIROMICS.
American journal of respiratory and critical care medicine
Article2025 - Home Dust Allergen Exposure Is Associated with Outcomes among Sensitized Individuals with Chronic Obstructive Pulmonary Disease.
American journal of respiratory and critical care medicine
Article2022 - Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT.
Annals of the American Thoracic Society
Article2022 - Obstructive Sleep Apnea and Airway Dimensions in Chronic Obstructive Pulmonary Disease.
Annals of the American Thoracic Society
Letter2020
Most-cited works
by citation count (OpenAlex)- 01Chronic obstructive pulmonary diseaseArticle1,217 citations2022
- 02
- 03
- 04
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/nirupama-putcha-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
resphealth.org/dr-nirupama-putcha-receives-2026-solovy-award-for-advancement-in-copd
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →resphealth.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University of Alabama at Birmingham
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lung.org ↗ - MHS in Epidemiology
Johns Hopkins Bloomberg School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lung.org ↗
Editorial & leadership roles
journal and society appointments- Member
American Thoracic Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lung.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lung.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Kenneth Pienta, MD
Johns Hopkins University School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Harry Quigley, MD
Johns Hopkins University School of Medicine
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital